CLINICAL DETECTION OF BCR-ABL FUSION BY INSITU HYBRIDIZATION IN CHRONIC MYELOGENOUS LEUKEMIA

被引：30
|
作者：
AMIEL, A
YARKONI, S
FEJGIN, M
GABER, E
NAGLER, A
MANOR, Y
LISHNER, M
机构：
[1] HADASSAH UNIV HOSP,DEPT BONE MARROW TRANSPLANTAT,JERUSALEM,ISRAEL
[2] MEIR HOSP,HEMATOL UNIT,IL-44281 KEFAR SAVA,ISRAEL
来源：
CANCER GENETICS AND CYTOGENETICS | 1993年 / 65卷 / 01期
关键词：
D O I：
10.1016/0165-4608(93)90055-Q
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We describe the use of the fluorescence in situ hybridization (FISH) technique to detect residual Philadelphia chromosome-positive (Ph+) cells in a patient with blastic phase chronic myelogenous leukemia (CML) after aggressive cytoreductive treatment. The analysis was made in interphase nuclei because of the very small number of recognizable metaphases in leukemic patients. FISH was a reliable tool for the detection of chromosome translocations in interphase nuclei as compared with conventional cytogenetic and polymerase chain reaction (PCR) techniques.
引用
收藏
页码：32 / 34
页数：3
相关论文
共 50 条
  • [21] BCR-ABL - AN ANTI-APOPTOSIS GENE IN CHRONIC MYELOGENOUS LEUKEMIA
    COTTER, TG
    LEUKEMIA & LYMPHOMA, 1995, 18 (3-4) : 231 - 236
  • [22] Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia
    O'Dwyer, ME
    Druker, BJ
    CURRENT OPINION IN ONCOLOGY, 2000, 12 (06) : 594 - 597
  • [23] Mechanism of stability and degradation of the chronic myelogenous leukemia oncoprotein, BCR-ABL
    Tsukahara, F
    Maru, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 105P - 105P
  • [24] Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more
    Cea, M.
    Cagnetta, A.
    Garuti, A.
    Cirmena, G.
    Rocco, I.
    Moran, E.
    Grillo, V.
    Ballestrero, A.
    Patrone, F.
    Nencioni, A.
    JOURNAL OF BUON, 2009, 14 (04): : 565 - 573
  • [25] ALTERNATIVE 5' END OF THE BCR-ABL TRANSCRIPT IN CHRONIC MYELOGENOUS LEUKEMIA
    ROMERO, P
    BERAN, M
    SHTALRID, M
    ANDERSSON, B
    TALPAZ, M
    BLICK, M
    ONCOGENE, 1989, 4 (01) : 93 - 98
  • [26] Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization
    Cohen, N
    Novikov, I
    Hardan, I
    Esa, A
    Brok-Simoni, F
    Amariglio, N
    Rechavi, G
    Ben-Bassat, I
    Trakhtenbrot, L
    CANCER GENETICS AND CYTOGENETICS, 2000, 123 (02) : 102 - 108
  • [27] Clinical Significance of BCR-ABL Fusion Gene Subtypes in Chronic Myelogenous and Acute Lymphoblastic Leukemias
    Ye, Yuan-Xin
    Zhou, Juan
    Zhou, Yan-Hong
    Zhou, Yi
    Song, Xing-Bo
    Wang, Jun
    Lin, Li
    Ying, Bin-Wu
    Lu, Xiao-Jun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (22) : 9961 - 9966
  • [28] BCR-ABL FUSION GENES IN HUMAN CHRONIC MYELOGENEOUS LEUKEMIA
    BOEHM, TLJ
    HIRTH, HP
    WERLE, A
    DRAHOVSKY, D
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1985, 366 (09): : 767 - 767
  • [29] Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
    Poonam, Jain P.
    Mayur, Parihar
    Rayaz, Ahmed
    Aby, Abraham
    Auro, Vishwabandya
    Biju, George
    Vikram, Mathews
    Alok, Srivastava
    Vivi, Srivastava M.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (03) : 347 - 351
  • [30] Clinical features influencing the detection of BCR-ABL transcripts after allogeneic bone marrow transplantation for chronic myelogenous leukemia
    Roman, J
    Garcia, MJ
    Martin, C
    Sanchez, J
    Serrano, J
    Falcon, M
    Castillejo, JA
    Navarro, JA
    Flores, R
    Torres, A
    MEDICINA CLINICA, 1998, 111 (11): : 405 - 409
12345